US Stock MarketDetailed Quotes

CRDF Cardiff Oncology

Watchlist
  • 2.460
  • +0.010+0.41%
Close Nov 26 16:00 ET
  • 2.420
  • -0.040-1.63%
Post 16:35 ET
125.79MMarket Cap-2589P/E (TTM)

Cardiff Oncology Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-31.41%-10.46M
-29.42%-9.23M
10.61%-7.74M
8.67%-30.89M
23.97%-7.14M
-6.29%-7.96M
-6.53%-7.13M
15.51%-8.66M
-46.79%-33.82M
-27.06%-9.39M
Net income from continuing operations
-21.83%-11.86M
-5.63%-11.78M
10.80%-10.01M
-7.07%-41.44M
-7.36%-9.34M
-13.53%-9.73M
-6.77%-11.15M
-2.09%-11.22M
-36.81%-38.7M
7.89%-8.7M
Operating gains losses
----
----
----
----
----
----
----
----
100.35%1K
----
Depreciation and amortization
-5.61%101K
7.14%105K
13.33%102K
68.64%398K
19.77%103K
32.10%107K
157.89%98K
190.32%90K
-47.67%236K
-23.89%86K
Other non cash items
----
----
----
----
----
----
----
----
-93.16%139K
--0
Change In working capital
-80.25%202K
-46.11%1.39M
-23.65%1.2M
1,828.42%6.57M
179.39%1.39M
791.22%1.02M
5.61%2.58M
270.24%1.57M
78.76%-380K
-8,660.00%-1.75M
-Change in receivables
-351.35%-167K
-111.26%-58K
-210.53%-105K
304.66%483K
25.62%-90K
62.63%-37K
595.19%515K
7.95%95K
-9.77%-236K
14.18%-121K
-Change in prepaid assets
-58.19%388K
-21.61%791K
-107.59%-95K
815.35%3.17M
95.75%-19K
6,728.57%928K
-12.94%1.01M
209.64%1.25M
78.89%-443K
67.08%-447K
-Change in payables and accrued expense
-100.74%-1K
-38.26%673K
597.04%1.42M
110.01%2.83M
6,000.00%1.4M
421.43%135K
-20.26%1.09M
--203K
87.48%1.35M
-98.52%23K
-Change in other current assets
0.72%139K
28.70%139K
-14.81%138K
207.96%651K
122.80%243K
0.73%138K
-22.30%108K
-13.37%162K
-178.01%-603K
-946.03%-1.07M
-Change in other current liabilities
-11.35%-157K
-9.22%-154K
-10.14%-152K
-26.91%-566K
-3.55%-146K
-8.46%-141K
-20.51%-141K
-137.93%-138K
53.88%-446K
28.06%-141K
Cash from discontinued investing activities
Operating cash flow
-31.41%-10.46M
-29.42%-9.23M
10.61%-7.74M
8.67%-30.89M
23.97%-7.14M
-6.29%-7.96M
-6.53%-7.13M
15.51%-8.66M
-46.79%-33.82M
-27.06%-9.39M
Investing cash flow
Cash flow from continuing investing activities
-346.90%-9.43M
22.04%14.02M
-36.74%4.64M
-5.12%36.2M
93.18%13.56M
-25.99%3.82M
50.95%11.48M
-60.08%7.33M
129.02%38.15M
179.83%7.02M
Capital expenditure reported
--0
--0
-900.00%-80K
42.15%-582K
89.33%-8K
29.69%-315K
19.55%-251K
95.32%-8K
-390.73%-1.01M
29.91%-75K
Net investment purchase and sale
-328.09%-9.43M
19.43%14.02M
-35.72%4.72M
-5.80%36.78M
91.25%13.57M
-25.72%4.14M
49.51%11.74M
-60.40%7.34M
129.75%39.04M
181.67%7.1M
Net other investing changes
----
----
----
----
----
----
----
----
--114K
--0
Cash from discontinued investing activities
Investing cash flow
-346.90%-9.43M
22.04%14.02M
-36.74%4.64M
-5.12%36.2M
93.18%13.56M
-25.99%3.82M
50.95%11.48M
-60.08%7.33M
129.02%38.15M
179.83%7.02M
Financing cash flow
Cash flow from continuing financing activities
7.43M
2.06M
107K
0
0
0
0
0
-99.79%75K
0
Net common stock issuance
--7.43M
----
----
----
----
--0
----
----
----
----
Proceeds from stock option exercised by employees
--0
--253K
--107K
--0
--0
--0
--0
--0
-94.06%75K
--0
Cash from discontinued financing activities
Financing cash flow
--7.43M
--2.06M
--107K
--0
--0
--0
--0
--0
-99.79%75K
--0
Net cash flow
Beginning cash position
31.66%25.5M
24.25%18.66M
32.47%21.66M
36.88%16.35M
-18.61%15.23M
-7.61%19.37M
-25.11%15.02M
36.88%16.35M
-90.88%11.94M
42.17%18.72M
Current changes in cash
-201.33%-12.46M
57.24%6.84M
-125.34%-3M
20.53%5.31M
370.97%6.42M
-83.99%-4.14M
376.67%4.35M
-116.40%-1.33M
103.70%4.4M
-93.94%-2.37M
End cash Position
-14.41%13.04M
31.66%25.5M
24.25%18.66M
32.47%21.66M
32.47%21.66M
-18.61%15.23M
-7.61%19.37M
-25.11%15.02M
36.88%16.35M
36.88%16.35M
Free cash flow
-26.40%-10.46M
-25.02%-9.23M
9.77%-7.82M
9.64%-31.47M
24.49%-7.15M
-4.26%-8.27M
-5.37%-7.38M
16.82%-8.67M
-49.82%-34.83M
-26.25%-9.47M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
--
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -31.41%-10.46M-29.42%-9.23M10.61%-7.74M8.67%-30.89M23.97%-7.14M-6.29%-7.96M-6.53%-7.13M15.51%-8.66M-46.79%-33.82M-27.06%-9.39M
Net income from continuing operations -21.83%-11.86M-5.63%-11.78M10.80%-10.01M-7.07%-41.44M-7.36%-9.34M-13.53%-9.73M-6.77%-11.15M-2.09%-11.22M-36.81%-38.7M7.89%-8.7M
Operating gains losses --------------------------------100.35%1K----
Depreciation and amortization -5.61%101K7.14%105K13.33%102K68.64%398K19.77%103K32.10%107K157.89%98K190.32%90K-47.67%236K-23.89%86K
Other non cash items ---------------------------------93.16%139K--0
Change In working capital -80.25%202K-46.11%1.39M-23.65%1.2M1,828.42%6.57M179.39%1.39M791.22%1.02M5.61%2.58M270.24%1.57M78.76%-380K-8,660.00%-1.75M
-Change in receivables -351.35%-167K-111.26%-58K-210.53%-105K304.66%483K25.62%-90K62.63%-37K595.19%515K7.95%95K-9.77%-236K14.18%-121K
-Change in prepaid assets -58.19%388K-21.61%791K-107.59%-95K815.35%3.17M95.75%-19K6,728.57%928K-12.94%1.01M209.64%1.25M78.89%-443K67.08%-447K
-Change in payables and accrued expense -100.74%-1K-38.26%673K597.04%1.42M110.01%2.83M6,000.00%1.4M421.43%135K-20.26%1.09M--203K87.48%1.35M-98.52%23K
-Change in other current assets 0.72%139K28.70%139K-14.81%138K207.96%651K122.80%243K0.73%138K-22.30%108K-13.37%162K-178.01%-603K-946.03%-1.07M
-Change in other current liabilities -11.35%-157K-9.22%-154K-10.14%-152K-26.91%-566K-3.55%-146K-8.46%-141K-20.51%-141K-137.93%-138K53.88%-446K28.06%-141K
Cash from discontinued investing activities
Operating cash flow -31.41%-10.46M-29.42%-9.23M10.61%-7.74M8.67%-30.89M23.97%-7.14M-6.29%-7.96M-6.53%-7.13M15.51%-8.66M-46.79%-33.82M-27.06%-9.39M
Investing cash flow
Cash flow from continuing investing activities -346.90%-9.43M22.04%14.02M-36.74%4.64M-5.12%36.2M93.18%13.56M-25.99%3.82M50.95%11.48M-60.08%7.33M129.02%38.15M179.83%7.02M
Capital expenditure reported --0--0-900.00%-80K42.15%-582K89.33%-8K29.69%-315K19.55%-251K95.32%-8K-390.73%-1.01M29.91%-75K
Net investment purchase and sale -328.09%-9.43M19.43%14.02M-35.72%4.72M-5.80%36.78M91.25%13.57M-25.72%4.14M49.51%11.74M-60.40%7.34M129.75%39.04M181.67%7.1M
Net other investing changes ----------------------------------114K--0
Cash from discontinued investing activities
Investing cash flow -346.90%-9.43M22.04%14.02M-36.74%4.64M-5.12%36.2M93.18%13.56M-25.99%3.82M50.95%11.48M-60.08%7.33M129.02%38.15M179.83%7.02M
Financing cash flow
Cash flow from continuing financing activities 7.43M2.06M107K00000-99.79%75K0
Net common stock issuance --7.43M------------------0----------------
Proceeds from stock option exercised by employees --0--253K--107K--0--0--0--0--0-94.06%75K--0
Cash from discontinued financing activities
Financing cash flow --7.43M--2.06M--107K--0--0--0--0--0-99.79%75K--0
Net cash flow
Beginning cash position 31.66%25.5M24.25%18.66M32.47%21.66M36.88%16.35M-18.61%15.23M-7.61%19.37M-25.11%15.02M36.88%16.35M-90.88%11.94M42.17%18.72M
Current changes in cash -201.33%-12.46M57.24%6.84M-125.34%-3M20.53%5.31M370.97%6.42M-83.99%-4.14M376.67%4.35M-116.40%-1.33M103.70%4.4M-93.94%-2.37M
End cash Position -14.41%13.04M31.66%25.5M24.25%18.66M32.47%21.66M32.47%21.66M-18.61%15.23M-7.61%19.37M-25.11%15.02M36.88%16.35M36.88%16.35M
Free cash flow -26.40%-10.46M-25.02%-9.23M9.77%-7.82M9.64%-31.47M24.49%-7.15M-4.26%-8.27M-5.37%-7.38M16.82%-8.67M-49.82%-34.83M-26.25%-9.47M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data